Private equity player The Carlyle Group has signed up to acquire a majority 74 per cent stake in Mumbai-headquartered animal health care company SeQuent Scientific for over Rs 1,500 crore. The transaction is being done through an equity purchase stake that values each share at Rs 86. The deal will be executed through two investment vehicles — CA Harbor Investments, affiliated entity of CAP V Mauritius, which is an affiliated entity of Carlyle. The deal is the Carlyle’s first majority transaction in India. SeQuent provides animal health active pharmaceutical ingredients formulations and analytical services in over 100 countries, with more than 1,700 employees and manufacturing operations in India, Spain, Turkey, Germany, and Brazil.

(Business Standard)